A Cambridge company researching treatments for blood cancers is ceasing operations and will lay off more than 150 people, ...

With our incredible universities, educated workforce and geographic location, I firmly believe Connecticut can be the next ...

Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare ...

Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.

KEY TAKEAWAYS French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for up to $9.5 billion, ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

BEAM Circular and the San Joaquin County Office of Education are teaming up to host two programs this month at the Durham ...

Sanofi paid $55 million to partner with the biotech in 2019 and handed over a further $22 million to expand the collaboration ...

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

New Biotech Communicators Network designed to strengthen community and relationships among biotech communicators.

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

FDA says a ‘statistically significant’ benefit on overall survival is required to approve the ivonescimab antibody.